Lanfranchi F, Belgioia L, Vita D, Passoni J, Mastrogiovanni S, Catanoso A, Sofia L, Pau V, Raffa S, Chiola S, Donegani MI, Piva R, Riondato M, Marcenaro M, Timon G, Marini C, Barra S, Sambuceti G, Bauckneht M. Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis. Ann Nucl Med, 2026; 40 (2): 178-187


Lanfranchi F, Belgioia L, Vita D, Passoni J, Mastrogiovanni S, Catanoso A, Sofia L, Pau V, Raffa S, Chiola S, Donegani MI, Piva R, Riondato M, Marcenaro M, Timon G, Marini C, Barra S, Sambuceti G, Bauckneht M. Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis. Ann Nucl Med, 2026; 40 (2): 178-187.